Guillermo Pepe Email & Phone Number

Founder & CEOMy mission is to help transform the current "sick care" system into a true healthcare system.I founded Mamotest to reduce the high breast cancer mortality rates caused by a lack of access to early diagnosis and patient journey support in underserved populations, stemming from a broken healthcare system.Mamotest is an AI-powered, patient-centered digital platform dedicated to defeating breast cancer. We are developing AI to democratize access to screening, diagnosis, and patient support. We collect anonymous medical and clinical data, as well as psychological and socio-economic information. This broader scope, combined with 100% patient traceability, allows us to provide vital information to global business and policy decision-makers, empowering them to save hundreds of thousands of women's lives.●2024 - 1.5M USD funding round led by Philips●2024 - Visionary Leadership Best Practices Recognition by Frost & Sullivan Institute●2024 - AWS success case in #LATAM, in #health●2024 - Speaker at FII Priority Summit, sponsored by PIF Saudi Arabia - Rio de Janeiro, Brazil●2024 - Latam Top 100 Innovators by Bloomberg ●2023 - Keynote Speaker at Experiencia Endeavor Buenos Aires, Argentina●2023 - 3.3M USD Pre-Series A Round led by J&J Impact Ventures. ●2023 - FAST COMPANY: 10 most innovative companies in Latin America.●2022 - Mamotest included in UNDP X Digital Catalogue.●2022 - NORRSKEN FOUNDATION Impact 100 nominee.● 2022 - World Economic Forum - Technology Pioneer● 2022 - Speaker at the Summit of the Americas - Los Angeles, USA● 2022 - Zayed Sustainability Prize Winner (600k USD) - health category● 2021 - United Nations Development Program. Selected as one of the most disruptive startups in health.● 2021 - 1.6M USD Seed Round led by Merck & Co (US).● 2020 - Winner project Chivas Venture Argentina & Uruguay. ● 2019 - Selected and subsidized by ANII to settle in Uruguay.● 2019 - “Global Humanitarian Award” American College of Radiology (the first Non US organization to be awarded)● 2019 - 30 Promises Argentina, Forbes Magazine.● 2018 - Field Global Partner Harvard University.● 2018 - Mamotest and Fundación Telmed are mentioned in 6 chapters of the best seller book "Regulatory Hacking". By Evan Burfield, USA.● 2017 - Winner Samsung Innova Impacto Social.● 2015 - Top 10 innovators Argentina, Brando Magazine.● 2015 - Selected as one of the 7 best Startups in Health in Latin America, by the Inter-American Development Bank (IDB).●2014 - I3 LATAM, Top 10 Social Impact Entrepreneurs LATAM